Home / Today’s Market / Short Squeeze Stocks: PPSI, NUZE and 3 Others Experts Think Are Ready to Pop Here are the top 5 short squeeze stocks according to Fintel By Eddie Pan, InvestorPlace Assistant News Writer Nov 29, 2021, 2:14 pm EST November 29, 2021 Short squeeze stocks are a subject frequently mentioned on…
Tag: NASDAQ:RNXT
Dear FSR Stock Fans, Mark Your Calendars for an EV Catalyst on Nov. 17
Fisker (NYSE:FSR) investors are going to want to keep an eye on FSR stock when Nov. 17 rolls around next Wednesday. Source: T. Schneider / Shutterstock.com A major catalyst for the stock could come that day when the company unveils its Fisker Ocean electric vehicle (EV). This is set to take place at the LA…
RNXT Stock Alert: 5 Things to Know as RenovoRx Soars 100%+ Today
RenovoRx (NASDAQ:RNXT) stock is rocketing higher today thanks to a presentation of data at a recent medical conference. Source: Shutterstock Let’s dive into that news below! Dr. Ripal Gandhi made a presentation last night including data from the Phase 3 TIGeR-PaC study. This study covers RenovoTAMP use in treating patients suffering from locally advanced pancreatic…
CEI Stock Alert: What Investors Are Saying About Camber Energy Today as Shares Soar
Camber Energy (NYSEAMERICAN:CEI) stock is taking off on Tuesday and that’s despite the company not releasing any recent news. Source: Shutterstock So what’s the reason for CEI stock running higher today! It all has to do with the meme stock rally that’s boosting shares. Camber Energy has actually been on the move since last week…
CLOV Stock: What Investors Are Saying About Clover Health Today as Shares Begin a Run Higher
Clover Health Investments (NASDAQ:CLOV) stock is on the rise Tuesday but it’s not due to any announcements from the healthcare company. Source: Vladeep / Shutterstock.com Instead, retail traders are eyeing shares of CLOV stock as a short-squeeze target. This isn’t a surprise as Clover Health Investments has been targeted for similar pumps in the past…
RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher Today
RenovoRx (NASDAQ:RNXT) stock is running higher on Tuesday following news that the U.S. Food and Drug Administration (FDA) granted it new 501(k) clearance. Source: Photographee.eu / Shutterstock.com This clearance allows the company to use its RenovoCath Delivery System to treat cancer tumors. It does so with RenovoGem. This is a combination of devices and drugs…